Tower Research Capital LLC (TRC) - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 25 filers reported holding MOLECULIN BIOTECH INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q4 2023$6,178
+0.9%
7,201
-49.7%
0.00%
Q3 2023$6,123
-26.4%
14,305
-0.5%
0.00%
Q2 2023$8,323
+69258.3%
14,374
+16.6%
0.00%
Q1 2023$12
+100.0%
12,329
+130.2%
0.00%
Q4 2022$6
-99.9%
5,355
-45.2%
0.00%
Q3 2022$10,000
+66.7%
9,772
+133.8%
0.00%
Q2 2022$6,000
-14.3%
4,180
-0.3%
0.00%
Q1 2022$7,0004,191
+10377.5%
0.00%
Q3 2021$0
-100.0%
40
-98.4%
0.00%
Q2 2021$9,0002,5130.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,040,529$3,122,0001.00%
OCCUDO QUANTITATIVE STRATEGIES LP 23,484$70,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 27,400$82,0000.00%
WELLS FARGO & COMPANY/MN 175$1,0000.00%
NORTHERN TRUST CORP 50,731$152,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 1,403$4,0000.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 20,198$61,0000.00%
OSAIC HOLDINGS, INC. 801$2,0000.00%
Rockefeller Capital Management L.P. 2,777$8,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders